World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
64
Citations
21647
World Ranking
7914
National Ranking
2296

Philip J. Hajduk publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Philip J. Hajduk sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 118 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Philip J. Hajduk D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Philip J. Hajduk sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 64 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Philip J. Hajduk is affiliated with the National Institutes of Health in the United States. Their research spans the fields of Biochemistry, Genetics, Molecular Biology, and Medicine, with particular focus on Molecular Biology, Genetics, and Immunology as subfields. Their work covers topics including Biochemical and Molecular Research, Toxin Mechanisms and Immunotoxins, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Cancer-related gene regulation.

Hajduk has contributed to multiple scientific publications. Notable recent papers include:

  • Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design, 2020, Journal of Medicinal Chemistry
  • Leveraging a Billion-Edge Knowledge Graph for Drug Re-purposing and Target Prioritization using Genomically-Informed Subgraphs, 2022, bioRxiv (Cold Spring Harbor Laboratory)

Their frequent coauthors consist of Justin Dietrich, Kenton L. Longenecker, Noel S. Wilson, Christian Goess, and Sanjay C. Panchal.

Hajduk's work has appeared primarily in the Journal of Medicinal Chemistry and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • An inhibitor of Bcl-2 family proteins induces regression of solid tumours

    Tilman Oltersdorf;Steven W. Elmore;Alexander R. Shoemaker;Robert C. Armstrong

  • Discovering High-Affinity Ligands for Proteins: SAR by NMR

    Suzanne B. Shuker;Philip J. Hajduk;Robert P. Meadows;Stephen W. Fesik

  • Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate.

    John E. Harlan;Philip J. Hajduk;Ho Sup Yoon;Stephen W. Fesik

  • A decade of fragment-based drug design: strategic advances and lessons learned

    Unknown

  • Druggability indices for protein targets derived from NMR-based screening data.

    Philip J. Hajduk;and Jeffrey R. Huth;Stephen W. Fesik

  • One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules

    Philip J. Hajduk;and Edward T. Olejniczak;Stephen W. Fesik

  • Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR

    P. J. Hajduk;G. Sheppard;D. G. Nettesheim;E. T. Olejniczak

  • Privileged molecules for protein binding identified from NMR-based screening.

    Philip J. Hajduk;Mark Bures;Jens Praestgaard;Stephen W. Fesik

  • Structural Characterization of a Soluble Amyloid β-Peptide Oligomer

    Liping Yu;Rohinton Edalji;John E. Harlan;Thomas F. Holzman

  • Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-xL from NMR and Parallel Synthesis

    Andrew M. Petros;Jurgen Dinges;David J. Augeri;Steven A. Baumeister

  • Predicting protein druggability.

    Philip J. Hajduk;Jeffrey R. Huth;Christin Tse

  • Navigating the kinome

    James T Metz;Eric F Johnson;Niru B Soni;Philip J Merta

  • Fragment-Based Drug Design: How Big Is Too Big?

    Philip J. Hajduk

  • Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy

    Bruce G Szczepankiewicz;Gang Liu;Philip J Hajduk;Cele Abad-Zapatero

  • Discovering High-Affinity Ligands for Proteins

    Philip J Hajduk;Robert P. Meadows;Stephen W. Fesik

  • NMR-based screening in drug discovery.

    Philip J. Hajduk;Robert P. Meadows;Stephen W. Fesik

  • Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein.

    Qiulong Huang;Liping Yu;Andrew M Petros;Angelo Gunasekera

  • NMR-Based Screening of Proteins Containing 13C-Labeled Methyl Groups

    Philip J. Hajduk;David J. Augeri;Jamey Mack;Renaldo Mendoza

  • Solution structure of a pleckstrin-homology domain.

    Ho Sup Yoon;Philip J. Hajduk;Andrew M. Petros;Edward T. Olejniczak

  • High-throughput nuclear magnetic resonance-based screening.

    Philip J. Hajduk;Tobias Gerfin;Jean-Marc Boehlen;Markus Häberli

  • ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens.

    Jeffrey R Huth;Renaldo Mendoza;Edward T Olejniczak;Robert W Johnson

Frequent Co-Authors

Stephen W. Fesik
Stephen W. Fesik Vanderbilt University
Edward T. Olejniczak
Edward T. Olejniczak Vanderbilt University
Saul H. Rosenberg
Saul H. Rosenberg AbbVie (United States)
Jun Chen
Jun Chen Nankai University
Eric F. Johnson
Eric F. Johnson AbbVie (United States)
Richard D. Smith
Richard D. Smith Pacific Northwest National Laboratory
Robert E. Johnson
Robert E. Johnson The University of Texas Medical Branch at Galveston
David Levens
David Levens National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of related online degrees and career opportunities. For those interested in law enforcement or legal studies, pursuing the best online criminal justice associate degree can be a great foundation. This path often leads to roles that intersect with scientific knowledge and legal regulations.

Another relevant option is earning a paralegal degree. Chemists with legal expertise can support intellectual property and patent law, especially in industries like pharmaceuticals and biotechnology.

For those focused on the pharmaceutical industry, becoming a pharmaceutical sales representative is a promising career. Understanding how much do pharmaceutical reps make reveals the potential financial benefits and growth opportunities in this field.

If a deeper scientific engagement is preferred, becoming a pharmacist requires significant commitment. Learning how much schooling to be a pharmacist helps students plan their education and career trajectory effectively.

Best Scientists Citing Philip J. Hajduk

Trending Scientists